"Modified Shengmaiyin" Affect Carotid Atherosclerosis In Clinical Research

Objective:Through the use of Modified ShengmaiYin carotid athero- sclerosis and clinical study of the theory to explain the medical effects of atherosclerosis in the clinical features, proposed Modified huangqi ShengmaiYin treat atherosclerosis, improve clinical Symptoms, to alleviate the suffering of patients.Methods:60 cases were divided into two groups at random:the treatment group of"Modified shengmaiyin"and routine western medicine and the control group of routine western medicine (Reasonable choice according to the disease in patients with hypertension taking antihypertensive drugs; coronary heart disease patients can still take isosorbide esters and other drugs; hyperlipidemic patients given a reasonable control of lipid drugs; diabetes drugs to control blood sugar; infarction patients according to Clinical treatment condition to be reasonable). The treatment cycle is 6 months. Changes of clinical symptoms,signs and lab indexes were detected before and after treatment.Results:6 months later,we found that total effective rate of treatment group was 90.0%,compared with control group,there are predominant difference(P<0.05).We find this therapy can Relieve symptoms in clinicalConclusion:"Modified Shengmaiyin"is testified to be effective for atherosclerosis,Modified shengmaiyin can regulate blood fat, improve endothelial function, vascular tone regulation, mitigation related to the role of vascular spasm.